Comprehensive Guide to Farxiga and Invokana in Diabetes Management

Diabetes is a chronic condition impacting how your body processes blood glucose. Type-2 diabetes affects individuals across all ages, including children and adults. Its main causes include genetics, obesity, and metabolic syndrome. Often mild in symptoms, diagnosis may require testing. Farxiga and Invokana are oral medications approved by the FDA, proven effective for managing Type 2 diabetes. These drugs help control blood sugar levels, especially when combined with lifestyle changes and proper diet.

Farxiga (Dapagliflozin)
Approved by the FDA in January 2014, dapagliflozin enhances blood sugar management when paired with diet and exercise. It is an SGLT2 inhibitor that reduces blood glucose by promoting its excretion via urine. Dapagliflozin is prescribed exclusively by a healthcare professional, with dosage tailored to the patient’s needs. Proper adherence, along with lifestyle modifications, can optimize results and minimize side effects.

Invokana (Canagliflozin)
Invokana is another SGLT2 inhibitor that helps lower blood sugar by preventing excess glucose reabsorption in the kidneys, leading to increased urination. Approved by the FDA in 2013, it offers benefits for type 2 diabetes patients who follow a proper diet and exercise routine. Clinical trials demonstrated significant improvements in hemoglobin A1C levels. Invokana can be combined with other medications like metformin to form FDA-approved treatment options, such as Invokamet.

Effective management with Farxiga or Invokana enables diabetics to maintain a healthy lifestyle and reduce complications associated with the disease.